In Silico Pharmacology provides a forum for research articles at the cross-roads of computation, pharmacology, toxicology and pharmaceutics, and is relevant to all areas of basic science and therapeutics. Within this context, neuroscience and drug discovery are areas of special interest to the journal, as are state-of-the-art multiscale modelling, informatics, artificial intelligence, and big data.
Journal information
- Editor-in-Chief
-
- Boris Gutkin,
- Pramod Nair,
- Defang Ouyang,
- Chang-Guo Zhan
- Publishing model
- Hybrid. Learn about publishing OA with us
Journal metrics
- 34 days
- Submission to first decision
- 164 days
- Submission to acceptance
- 12,761 (2019)
- Downloads
Latest issue
Latest articles
-
-
Molecular docking and pharmacophoric modelling of 1,5-disubstituted tetrazoles as inhibitors of two proteins present in cancer, the ABL and the mutated T315I kinase
Authors (first, second and last of 4)
-
-
Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2
Authors (first, second and last of 6)
-
In silico predictions on the possible mechanism of action of selected bioactive compounds against breast cancer
Authors (first, second and last of 11)
About this journal
- Electronic ISSN
- 2193-9616
- Abstracted and indexed in
-
- BIOSIS
- CNKI
- Dimensions
- EBSCO Academic Search
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Meta
- Naver
- OCLC WorldCat Discovery Service
- ProQuest Advanced Technologies & Aerospace Database
- ProQuest Central
- ProQuest Computer Science
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Pharma Collection
- ProQuest SciTech Premium Collection
- ProQuest Technology Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- PubMedCentral
- Qinsight
- Reaxys
- TD Net Discovery Service
- Copyright information
